12:00 AM
Nov 13, 2006
 |  BioCentury  |  Finance

Medarex option grants

Medarex option grants

From 1996-2005, the top executives at Medarex (MEDX) have realized at least $41.8 million from the exercise of stock options, $40.5M of which came from the genomic bubble years of 1999 and 2000. Donald Drakeman and Michael Appelbaum were the top moneymakers from the options, realizing $10.7 million and $18.8 million, respectively, from 1996-2005. Value realized and options granted figures in 2001-2005 for Appelbaum were not disclosed in MEDX's DEF 14A filings, as he was not listed as...

Read the full 380 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >